Stockreport

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

Elutia, Inc. - Class A  (ELUT) 
PDF SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Mi [Read more]